Search Results 131-140 of 17063 for Ribosome
This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This rare soft tissue cancer affects children more often than adults. Treatment may include surgery, chemotherapy and radiation therapy.
The Clinical Core of the Center for Cell Signaling in Gastroenterology supports faculty research by facilitating access to human biospecimens through two ...
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol.
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
Mayo Clinic's Cellular Microsystems and Biosensors Lab seeks to employ microfluidic devices to culture patient-derived cells or tissue for personalized ...
Mayo Clinic's Genetic Screening and Engineering Core provides amplification and sequencing quality control for preexisting CRISPR library plasmids.
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.